InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+26.3%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Wahlstrom Mats, 董事. Insider active across 3 companies, notably TriSalus Life Sciences, Inc.. In total, 9 reports have been recorded. Breakdown: 2 buys · 1 sell. Total volume traded: €95k. Activity tracked since 25 February 2022. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wahlstrom Mats
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
30,000 股0Common StockSEC:0001610717-26-000201:0
37,602 股0Common StockSEC:0001628280-26-035667:0
99,988 股@ US$0.738934.0% 占其流量Common StockSEC:0001610717-25-000145:0
25,188 股@ US$3.9776.2% 占其流量Common StockSEC:0001415889-24-029907:0
5,000 股@ US$4.5517.4% 占其流量Common StockSEC:0001415889-24-027656:0
标准退出：2025年2月20日 (T+90)
2,040 股@ US$4.166.4% 占其流量Common StockSEC:0001415889-24-027587:0
标准退出：2025年2月18日 (T+90)
99,988 股0Common StockSEC:0001610717-24-000060:0
14,997 股@ US$1.66718.2% 占其流量Common StockSEC:0001610717-24-000044:0
10,006 股@ US$11.636354.0% 占其流量Common StockSEC:0001567619-22-005922:0
9 条申报中的 9 条
About Wahlstrom Mats
Wahlstrom Mats is Administrateur at TriSalus Life Sciences, Inc., Coherus BioSciences, Inc. and Coherus Oncology, Inc. He has 9 filings in total. In the 9 recent filings we hold, buys amount to EUR 29730 and sells to EUR 65487, over the period from 2022-03-01 to 2026-06-09. The most common transaction nature is Attribution.
